RxFinder.ai

Dabigatran Etexilate

DABIGATRAN, Pradaxa

NADAC/unit $0.8830
No Shortage Tier 1: 60.2% 8 Manufacturers 23 ANDAs
vs. brand DABIGATRAN: Generic saves up to 91% per unit

Market Intelligence

2024-12-18 Class II Recall: Ascend Laboratories, LLC
2024-12-18 Class II Recall: Ascend Laboratories, LLC
2023-04-05 Class II Recall: Ascend Laboratories, LLC
2023-04-05 Class II Recall: Ascend Laboratories, LLC

Generic Manufacturers

ALEMBIC PHARMACEUTICALS LTDALKEM LABORATORIES LTDAPOTEX INCAUROBINDO PHARMA LTDBOEHRINGER INGELHEIM PHARMACEUTICALS INCDR REDDYS LABORATORIES LTDHETERO LABS LTD UNIT IIIMSN LABORATORIES PRIVATE LTDMYLAN PHARMACEUTICALS INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Dabigatran Etexilatedrfinder.aiFind doctors who prescribe Dabigatran Etexilateclinicalrx.aiClinical profile: Dabigatran Etexilaterxnews.aiLatest news about Dabigatran Etexilate

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.